Suppr超能文献

从人诱导多能干细胞衍生的视网膜类器官中分离的 CD73 阳性感光细胞的鉴定与移植。

Characterization and Transplantation of CD73-Positive Photoreceptors Isolated from Human iPSC-Derived Retinal Organoids.

机构信息

Institut de la Vision, Sorbonne Université, INSERM, CNRS, 17, Rue Moreau, Paris 75012, France.

INSERM U861, UEVE, CECS, AFM, Institute for Stem Cell Therapy and Exploration of Monogenic Diseases, Corbeil-Essonnes 91100, France.

出版信息

Stem Cell Reports. 2018 Sep 11;11(3):665-680. doi: 10.1016/j.stemcr.2018.07.005. Epub 2018 Aug 9.

Abstract

Photoreceptor degenerative diseases are a major cause of blindness for which cell replacement is one of the most encouraging strategies. For stem cell-based therapy using human induced pluripotent stem cells (hiPSCs), it is crucial to obtain a homogenous photoreceptor cell population. We confirmed that the cell surface antigen CD73 is exclusively expressed in hiPSC-derived photoreceptors by generating a fluorescent cone rod homeobox (Crx) reporter hiPSC line using CRISPR/Cas9 genome editing. We demonstrated that CD73 targeting by magnetic-activated cell sorting (MACS) is an effective strategy to separate a safe population of transplantable photoreceptors. CD73+ photoreceptor precursors can be isolated in large numbers and transplanted into rat eyes, showing capacity to survive and mature in close proximity to host inner retina of a model of photoreceptor degeneration. These data demonstrate that CD73+ photoreceptor precursors hold great promise for a future safe clinical translation.

摘要

光感受器退行性疾病是导致失明的主要原因之一,而细胞替代是最有前途的策略之一。对于基于干细胞的治疗,使用人诱导多能干细胞(hiPSC),获得同质的光感受器细胞群体至关重要。我们通过使用 CRISPR/Cas9 基因组编辑生成荧光视锥杆同源盒(Crx)报告 hiPSC 系,证实细胞表面抗原 CD73 仅在 hiPSC 衍生的光感受器中表达。我们证明,通过磁激活细胞分选(MACS)靶向 CD73 是分离安全的可移植光感受器群体的有效策略。可以大量分离 CD73+光感受器前体,并将其移植到大鼠眼中,在光感受器退行性病变模型中,显示出在与宿主内视网膜接近的位置存活和成熟的能力。这些数据表明,CD73+光感受器前体具有很大的临床转化为安全治疗的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b7/6135113/78bff4b0b76e/fx1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验